Annual report pursuant to Section 13 and 15(d)

Note 2 - Summary of Significant Accounting Policies (Tables)

v3.20.4
Note 2 - Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2020
Notes Tables  
Cumulative Effect of Adjustments for New Accounting Pronouncements on Balance Sheet [Table Text Block]
   
 
 
 
 
Adjustments
 
 
 
 
 
 
   
 
 
 
 
Due to
 
 
 
 
 
 
   
December 31,
   
Adoption of
 
 
 
January 1,
 
   
2018
   
ASC 842
 
 
 
2019
 
                           
Other assets
  $
171
    $
629
(1)
    $
800
 
Total assets
  $
46,834
    $
629
(1)
    $
47,463
 
Accrued liabilities
  $
6,766
    $
230
(2)
    $
6,996
 
Total current liabilities
  $
10,760
    $
230
(2)
    $
10,990
 
Other noncurrent liabilities
  $
634
    $
399
(2)
    $
1,033
 
Total liabilities
  $
41,922
    $
629
(2)
    $
42,551
 
Total liabilities and stockholders' equity
  $
46,834
    $
629
(2)
    $
47,463
 
Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]
   
December 31,
   
December 31,
   
 
 
 
   
2020
   
2019
   
Change
 
                         
Customer contracts liabilities:
                       
Marketing programs
  $
17
    $
108
    $
(91
)
Total
  $
17
    $
108
    $
(91
)
Revenue from External Customers by Geographic Areas [Table Text Block]
   
Year Ended
 
   
December
31,
 
   
2020
   
2019
 
                 
                 
Asia Pacific
  $
2,732
    $
2,349
 
United States
   
2,537
     
3,672
 
Canada
   
110
     
277
 
Europe and Middle East
   
86
     
254
 
Latin America
   
14
     
15
 
Total
  $
5,479
    $
6,567
 
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
   
December
31,
 
   
2020
   
2019
 
                 
Convertible preferred stock:
               
Series A convertible preferred stock
   
-
(a)
   
185,218
 
Series B convertible preferred stock
   
2,341,111
(b)
   
2,070,458
 
Warrants to purchase common stock
   
1,728,725
 
   
2,473,785
 
Stock options to purchase common stock
   
986,399
 
   
1,008,833
 
Deferred restricted common stock awards
   
394
 
   
277